Insider Trading activities at Urogen Pharma Ltd. (URGN)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Urogen Pharma Ltd. (URGN) since 2017 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Urogen Pharma Ltd.. Table 2 shows the detailed insider transactions. This company's CIK number is 1668243.

Total stock buying since 2017: $791,523.
Total stock sales since 2017: $10,761,049.
Total stock option exercises since 2017: $2,231,408.

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at *Urogen Pharma Ltd.* (*URGN*).
	Insider Buying		Insider Sales		Option Exercises
Year	Shares	Value	Shares	Value	Shares	Value
2025	0	$0	39,763	$590,365	59,167	$0
2024	0	$0	28,315	$405,357	37,498	$0
2023	0	$0	7,336	$104,222	156,510	$613,385
2022	0	$0	61,770	$541,591	304,545	$832,410
2021	5,160	$80,996	8,609	$120,985	34,714	$16,205
2020	10,000	$185,000	7,939	$195,148	222,578	$0
2019	18,780	$525,527	8,732	$305,511	164,687	$769,408
2017	0	$0	209,298	$8,497,870	0	$0

Table 2. Monthly summary of insider trading at *Urogen Pharma Ltd.* (*URGN*).
Trading Period	Insider Buying		Insider Sales		Option Exercises
year-month	Shares	Value	Shares	Value	Shares	Value
2025-08	0	$0	10,000	$176,900	0	$0
2025-07	0	$0	12,671	$242,522	26,500	$0
2025-06	0	$0	5,162	$38,043	10,000	$0
2025-01	0	$0	11,930	$132,900	22,667	$0
2024-09	0	$0	2,380	$31,129	7,499	$0
2024-06	0	$0	5,153	$67,401	10,000	$0
2024-03	0	$0	12,000	$168,600	0	$0
2024-01	0	$0	8,782	$138,227	19,999	$0
2023-08	0	$0	3,800	$68,438	8,334	$0
2023-01	0	$0	3,536	$35,784	148,176	$613,385
2022-10	0	$0	258	$3,057	500	$0
2022-09	0	$0	0	$0	160,000	$800,000
2022-08	0	$0	3,865	$28,021	11,574	$16,205
2022-07	0	$0	0	$0	500	$0
2022-06	0	$0	0	$0	3,241	$16,205
2022-04	0	$0	254	$1,681	500	$0
2022-01	0	$0	57,393	$508,832	128,230	$0
2021-11	160	$2,096	6,648	$81,298	13,333	$0
2021-10	0	$0	107	$1,746	708	$0
2021-08	0	$0	243	$3,800	0	$0
2021-07	0	$0	103	$1,575	708	$0
2021-05	5,000	$78,900	0	$0	0	$0
2021-04	0	$0	332	$6,607	709	$0
2021-03	0	$0	0	$0	3,241	$16,205

Table 3. Detailed insider trading at *Urogen Pharma Ltd.* (*URGN*)
Trade Date	Insider Name	Trade Type	Shares	Price ($)	Value ($)
2025-08-11	Schoenberg Mark (Chief Medical Officer)	Sale	10,000	17.69	176,900
2025-07-28	Smith Jason Drew (General Counsel)	Sale	7,522	19.14	143,971
2025-07-28	Smith Jason Drew (General Counsel)	Option Ex	16,500	.00	0
2025-07-28	Schoenberg Mark (Chief Medical Officer)	Sale	5,149	19.14	98,551
2025-07-28	Schoenberg Mark (Chief Medical Officer)	Option Ex	10,000	.00	0
2025-06-09	Schoenberg Mark (Chief Medical Officer)	Sale	5,162	7.37	38,043
2025-06-08	Schoenberg Mark (Chief Medical Officer)	Option Ex	10,000	.00	0
2025-01-31	Smith Jason Drew (General Counsel)	Sale	7,379	11.14	82,202
2025-01-31	Smith Jason Drew (General Counsel)	Option Ex	14,667	.00	0
2025-01-31	Schoenberg Mark (Chief Medical Officer)	Sale	4,551	11.14	50,698
2025-01-31	Schoenberg Mark (Chief Medical Officer)	Option Ex	8,000	.00	0
2024-09-09	Kim Dong (Chief Financial Officer)	Option Ex	2,500	.00	0
2024-09-09	Smith Jason Drew (General Counsel)	Sale	1,521	13.08	19,894
2024-09-09	Smith Jason Drew (General Counsel)	Option Ex	3,333	.00	0
2024-09-09	Schoenberg Mark (Chief Medical Officer)	Sale	859	13.08	11,235
2024-09-09	Schoenberg Mark (Chief Medical Officer)	Option Ex	1,666	.00	0
2024-06-10	Schoenberg Mark (Chief Medical Officer)	Sale	5,153	13.08	67,401
2024-06-10	Schoenberg Mark (Chief Medical Officer)	Option Ex	10,000	.00	0
2024-03-18	Schoenberg Mark (Chief Medical Officer)	Sale	12,000	14.05	168,600
2024-01-31	Kim Dong (Chief Financial Officer)	Option Ex	3,333	.00	0
2024-01-31	Smith Jason Drew (General Counsel)	Sale	4,993	15.74	78,589
2024-01-31	Smith Jason Drew (General Counsel)	Option Ex	10,000	.00	0
2024-01-31	Schoenberg Mark (Chief Medical Officer)	Sale	3,789	15.74	59,638
2024-01-31	Schoenberg Mark (Chief Medical Officer)	Option Ex	6,666	.00	0
2023-08-31	Smith Jason Drew (General Counsel)	Sale	3,800	18.01	68,438
2023-08-31	Smith Jason Drew (General Counsel)	Option Ex	8,334	.00	0
2023-01-31	Smith Jason Drew (General Counsel)	Sale	1,636	10.12	16,556
2023-01-31	Smith Jason Drew (General Counsel)	Option Ex	3,333	.00	0
2023-01-31	Barrett Elizabeth A. (Chief Executive Officer)	Option Ex	18,333	.00	0
2023-01-31	Schoenberg Mark (Chief Medical Officer)	Sale	1,900	10.12	19,228
2023-01-31	Schoenberg Mark (Chief Medical Officer)	Option Ex	3,833	.00	0
2023-01-20	Schoenberg Mark (Chief Medical Officer)	Option Ex	122,677	5.00	613,385
2022-10-31	Schoenberg Mark (Chief Medical Officer)	Sale	258	11.85	3,057
2022-10-31	Schoenberg Mark (Chief Medical Officer)	Option Ex	500	.00	0
2022-09-14	Belldegrun Arie (Director)	Option Ex	160,000	5.00	800,000
2022-08-31	Smith Jason Drew (General Counsel)	Sale	3,606	7.21	25,999
2022-08-31	Smith Jason Drew (General Counsel)	Option Ex	8,333	.00	0
2022-08-31	Belldegrun Arie (Director)	Option Ex	3,241	5.00	16,205
2022-08-01	Schoenberg Mark (Chief Medical Officer)	Sale	259	7.81	2,022
2022-07-31	Schoenberg Mark (Chief Medical Officer)	Option Ex	500	.00	0
2022-06-16	Nussbaum Ran (Director)	Option Ex	2,211	5.00	11,055
2022-06-06	Nussbaum Ran (Director)	Option Ex	1,030	5.00	5,150
2022-04-30	Schoenberg Mark (Chief Medical Officer)	Sale	254	6.62	1,681
2022-04-30	Schoenberg Mark (Chief Medical Officer)	Option Ex	500	.00	0
2022-01-31	Smith Jason Drew (General Counsel)	Sale	414	7.58	3,138
2022-01-31	Smith Jason Drew (General Counsel)	Option Ex	833	.00	0
2022-01-31	Barrett Elizabeth A. (Chief Executive Officer)	Sale	8,195	7.58	62,118
2022-01-31	Barrett Elizabeth A. (Chief Executive Officer)	Option Ex	18,333	.00	0
2022-01-31	Schoenberg Mark (Chief Medical Officer)	Sale	1,374	7.58	10,414
2022-01-31	Schoenberg Mark (Chief Medical Officer)	Option Ex	2,500	.00	0
2022-01-31	Henderson Molly (Chief Financial Officer)	Sale	331	7.58	2,508
2022-01-31	Henderson Molly (Chief Financial Officer)	Option Ex	666	.00	0
2022-01-26	Schoenberg Mark (Chief Medical Officer)	Sale	111	8.09	897
2022-01-26	Schoenberg Mark (Chief Medical Officer)	Option Ex	209	.00	0
2022-01-04	Barrett Elizabeth A. (Chief Executive Officer)	Sale	46,968	9.15	429,757
2022-01-03	Barrett Elizabeth A. (Chief Executive Officer)	Option Ex	105,689	.00	0
2021-11-30	Smith Jason Drew (General Counsel)	Sale	3,803	12.03	45,750
2021-11-30	Smith Jason Drew (General Counsel)	Option Ex	8,333	.00	0
2021-11-30	Henderson Molly (Chief Financial Officer)	Sale	2,587	12.03	31,121
2021-11-30	Henderson Molly (Chief Financial Officer)	Option Ex	5,000	.00	0
2021-11-18	Schoenberg Mark (Chief Medical Officer)	Buy	160	13.10	2,096
2021-11-01	Schoenberg Mark (Chief Medical Officer)	Sale	258	17.16	4,427
2021-10-31	Schoenberg Mark (Chief Medical Officer)	Option Ex	500	.00	0
2021-10-27	Schoenberg Mark (Chief Medical Officer)	Sale	107	16.32	1,746
2021-10-26	Schoenberg Mark (Chief Medical Officer)	Option Ex	208	.00	0
2021-08-02	Schoenberg Mark (Chief Medical Officer)	Sale	243	15.64	3,800
2021-07-31	Schoenberg Mark (Chief Medical Officer)	Option Ex	500	.00	0
2021-07-26	Schoenberg Mark (Chief Medical Officer)	Sale	103	15.30	1,575
2021-07-26	Schoenberg Mark (Chief Medical Officer)	Option Ex	208	.00	0
2021-05-17	Smith Jason Drew (General Counsel)	Buy	2,500	15.71	39,275
2021-05-17	Henderson Molly (Chief Financial Officer)	Buy	2,500	15.85	39,625
2021-04-30	Schoenberg Mark (Chief Medical Officer)	Sale	243	20.00	4,860
2021-04-30	Schoenberg Mark (Chief Medical Officer)	Option Ex	500	.00	0
2021-04-26	Schoenberg Mark (Chief Medical Officer)	Sale	89	19.63	1,747
2021-04-26	Schoenberg Mark (Chief Medical Officer)	Option Ex	209	.00	0
2021-03-24	Belldegrun Arie (Director)	Option Ex	3,241	5.00	16,205
2021-01-31	Barrett Elizabeth A. (Chief Executive Officer)	Option Ex	5,000	.00	0
2021-01-31	Schoenberg Mark (Chief Medical Officer)	Sale	1,076	22.07	23,747
2021-01-31	Schoenberg Mark (Chief Medical Officer)	Option Ex	2,000	.00	0
2021-01-26	Schoenberg Mark (Chief Medical Officer)	Sale	100	22.12	2,212
2021-01-26	Schoenberg Mark (Chief Medical Officer)	Option Ex	208	.00	0
2021-01-03	Barrett Elizabeth A. (Chief Executive Officer)	Option Ex	8,807	.00	0
2020-12-14	Barrett Elizabeth A. (Chief Executive Officer)	Buy	10,000	18.50	185,000
2020-12-04	Barrett Elizabeth A. (Chief Executive Officer)	Option Ex	61,652	.00	0
2020-12-04	Schoenberg Mark (Chief Medical Officer)	Sale	662	19.85	13,140
2020-12-04	Schoenberg Mark (Chief Medical Officer)	Option Ex	1,042	.00	0
2020-10-26	Schoenberg Mark (Chief Medical Officer)	Sale	101	20.95	2,115
2020-10-26	Schoenberg Mark (Chief Medical Officer)	Option Ex	208	.00	0
2020-10-15	Pfreundschuh Peter P. (Chief Financial Officer)	Sale	2,400	21.78	52,274
2020-10-15	Pfreundschuh Peter P. (Chief Financial Officer)	Option Ex	4,917	.00	0
2020-09-04	Schoenberg Mark (Chief Medical Officer)	Sale	348	20.20	7,029
2020-09-04	Schoenberg Mark (Chief Medical Officer)	Option Ex	1,041	.00	0
2020-09-01	Pfreundschuh Peter P. (Chief Financial Officer)	Sale	509	22.82	11,615
2020-09-01	Pfreundschuh Peter P. (Chief Financial Officer)	Option Ex	1,042	.00	0
2020-07-27	Schoenberg Mark (Chief Medical Officer)	Sale	70	23.51	1,645
2020-07-27	Pfreundschuh Peter P. (Chief Financial Officer)	Sale	141	23.51	3,314
2020-07-26	Schoenberg Mark (Chief Medical Officer)	Option Ex	209	.00	0
2020-07-26	Pfreundschuh Peter P. (Chief Financial Officer)	Option Ex	417	.00	0
2020-06-04	Schoenberg Mark (Chief Medical Officer)	Sale	349	27.51	9,602
2020-06-04	Schoenberg Mark (Chief Medical Officer)	Option Ex	1,042	.00	0
2020-05-20	Pfreundschuh Peter P. (Chief Financial Officer)	Sale	358	25.07	8,975
2020-05-20	Pfreundschuh Peter P. (Chief Financial Officer)	Option Ex	1,041	.00	0
2020-05-12	Barrett Elizabeth A. (Chief Executive Officer)	Option Ex	35,229	.00	0
2020-04-27	Mullennix Stephen (Chief Operating Officer)	Sale	145	24.35	3,530
2020-04-27	Schoenberg Mark (Chief Medical Officer)	Sale	70	24.35	1,704
2020-04-27	Pfreundschuh Peter P. (Chief Financial Officer)	Sale	141	24.35	3,433
2020-04-26	Mullennix Stephen (Chief Operating Officer)	Option Ex	417	.00	0
2020-04-26	Schoenberg Mark (Chief Medical Officer)	Option Ex	208	.00	0
2020-04-26	Pfreundschuh Peter P. (Chief Financial Officer)	Option Ex	417	.00	0
2020-03-04	Schoenberg Mark (Chief Medical Officer)	Option Ex	1,042	.00	0
2020-02-20	Pfreundschuh Peter P. (Chief Financial Officer)	Sale	360	29.68	10,684
2020-02-20	Pfreundschuh Peter P. (Chief Financial Officer)	Option Ex	1,042	.00	0
2020-02-14	Mullennix Stephen (Chief Operating Officer)	Sale	612	28.04	17,160
2020-02-14	Mullennix Stephen (Chief Operating Officer)	Option Ex	1,759	.00	0
2020-01-27	Mullennix Stephen (Chief Operating Officer)	Sale	684	29.26	20,013
2020-01-27	Schoenberg Mark (Chief Medical Officer)	Sale	322	29.15	9,386
2020-01-27	Pfreundschuh Peter P. (Chief Financial Officer)	Sale	667	29.28	19,529
2020-01-26	Mullennix Stephen (Chief Operating Officer)	Option Ex	1,666	.00	0
2020-01-26	Schoenberg Mark (Chief Medical Officer)	Option Ex	833	.00	0
2020-01-26	Pfreundschuh Peter P. (Chief Financial Officer)	Option Ex	1,666	.00	0
2020-01-03	Barrett Elizabeth A. (Chief Executive Officer)	Option Ex	105,688	.00	0
2019-12-04	Schoenberg Mark (Chief Medical Officer)	Option Ex	1,042	.00	0
2019-11-21	Barrett Elizabeth A. (Chief Executive Officer)	Buy	7,530	28.00	210,840
2019-11-20	Barrett Elizabeth A. (Chief Executive Officer)	Buy	7,470	28.00	209,160
2019-11-20	Pfreundschuh Peter P. (Chief Financial Officer)	Sale	354	28.41	10,057
2019-11-20	Pfreundschuh Peter P. (Chief Financial Officer)	Option Ex	1,042	.00	0
2019-11-19	Schoenberg Mark (Chief Medical Officer)	Buy	1,960	28.17	55,213
2019-11-15	Barrett Elizabeth A. (Chief Executive Officer)	Buy	1,548	26.00	40,248
2019-11-14	Mullennix Stephen (Chief Operating Officer)	Sale	608	26.00	15,806
2019-11-14	Mullennix Stephen (Chief Operating Officer)	Option Ex	1,759	.00	0
2019-09-04	Schoenberg Mark (Chief Medical Officer)	Sale	343	33.92	11,634
2019-09-04	Schoenberg Mark (Chief Medical Officer)	Option Ex	1,041	.00	0
2019-08-20	Pfreundschuh Peter P. (Chief Financial Officer)	Sale	1,416	33.07	46,827
2019-08-20	Pfreundschuh Peter P. (Chief Financial Officer)	Option Ex	4,167	.00	0
2019-08-15	Mullennix Stephen (Chief Operating Officer)	Sale	608	31.65	19,243
2019-08-14	Mullennix Stephen (Chief Operating Officer)	Option Ex	1,759	.00	0
2019-06-04	Schoenberg Mark (Chief Medical Officer)	Option Ex	1,042	.00	0
2019-05-14	Mullennix Stephen (Chief Operating Officer)	Sale	608	37.98	23,091
2019-05-14	Mullennix Stephen (Chief Operating Officer)	Option Ex	1,759	.00	0
2019-03-27	Belldegrun Arie (Director)	Option Ex	128,000	4.02	514,559
2019-03-21	Schoenberg Mark (Chief Medical Officer)	Buy	272	37.01	10,066
2019-03-06	Schoenberg Mark (Chief Medical Officer)	Sale	1,991	37.30	74,264
2019-03-04	Schoenberg Mark (Chief Medical Officer)	Option Ex	1,042	.00	0
2019-02-14	Mullennix Stephen (Chief Operating Officer)	Sale	2,804	37.30	104,589
2019-02-14	Mullennix Stephen (Chief Operating Officer)	Option Ex	7,034	.00	0
2019-02-06	Cohen Fred E (Director)	Option Ex	15,000	16.99	254,849
2017-11-28	Schreiber Alain (10% Owner)	Sale	177,807	40.51	7,202,961
2017-11-27	Schreiber Alain (10% Owner)	Sale	31,491	41.12	1,294,909

Insider trading activities including stock purchases, stock sales, and option exercises of URGN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Urogen Pharma Ltd. (symbol URGN, CIK number 1668243) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month